Galectin-3 in prostatic tumours: Immunohistochemistry and digital image analysis;Galectina-3 em tumores de próstata: Imuno-histoquímica e análise digital de imagens

Jornal Brasileiro de Patologia e Medicina Laboratorial

Volumn 42, Issue 6, 2006, Pages 469-475

  Araújo Filho, Jorge Luiz Silva ^a   De Melo Jr , Mario Ribeiro ^a,b   Lins, Consuelo Antunes Barreto ^c   Lins, Romero Antunes Barreto ^a   Machado, Marcos Cezar Feitosa De P ^a   De Carvalho Jr , Luiz Bezerra ^a   De Pontes Filho, Nicodemos Teles ^a  

^a FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^b Associação Caruaruense de Ensino Superior ASCES   (Brazil)

^c FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

Author keywords

Digital image analysis; Galectin 3; Prostate; Tumour

Indexed keywords

EID: 33846865291     PISSN: 16762444     EISSN: 16784774     Source Type: Journal    
DOI: 10.1590/S1676-24442006000600011     Document Type: Article

References (50)

1. AGRWAL, N.; WANG, J. L.; VOSS, P. G. Carbohydrate-binding protein 35. Levels of transcription and mRNA accumulation in quiescent and proliferating cells. J Biol Chem, v. 264, p. 17236-42, 1989.
2. BARBOSA-JÚNIOR, A. A. Morphological computer-assisted quantitative estimation of stained fibrous tissue in liver sections: applications in diagnosis and experimental research. J Bras Patol, v. 37(3), p. 197-200, 2001.
3. BOAG, A. H.; KENNEDY, L. A.; MILLER, M. J. Three-dimensional microscopic image reconstr uction of prostatic adenocarcinoma. Arch Pathol Lab Med, v. 125(4), p. 562-6, 2001.
4. CALIFICE, S. et al. Dual activities of galectin-3 in human prostate cancer: tumor suppression of nuclear galectin-3 vs. tumor promotion of cytoplasmic galectin-3. Oncogene, v. 23, p. 7527-36, 2004a.
5. CALIFICE, S.; CASTRONOVO, V.; VAN DEN BRULE, F. Galectin-3 and cancer (Review). Int J Oncol, v. 25(4), p. 983-92, 2004b.
6. CHAN, F. L.; CHOI, H. L.; HO, S. M. Analysis of glycoconjugate patterns of normal and hormone-induced dysplastic noble rat prostates and an androgen-independent noble rat prostate tumor by lectin and protein blotting. Prostate, v. 46(1), p. 21-32, 2001.
7. CHERAYIL, B. J. et al. Molecular cloning of a human macrophage lectin specific for galactose. Proc Natl Acad Sci USA, v. 87, p. 7324-8,1990.
8. DANIELSEN, H. E.; KILDAL, W.; SUBDO, J. Digital image analysis in pathology: exemplified in prostatic cancer. Tidsskr Nor Laeg, v. 120(4), p. 479-88, 2000.
9. DUMIC, J.; DABELIC, S.; FLÖGEL, M. Galectin-3: an open-ended story. Biochim Biophys Acta. v. 1760, n. 4, p. 616-35, 2006.
10. ELLERHORST, A. et al. Galectin-1 and galectin-3 expression in human prostate tissue and prostate cancer. Urol Res, v. 27, p. 362-7, 1999.
11. ELLERHORST, J. et al. Differential expression of endogenous galectin-1 and galectin-3 in human prostate cancer cell lines and effects of overexpressing galectin-1 on cell phenotype. Int J Oncol, v. 14, p. 217-24, 2002.
12. ELOLA, M. T. et al. Galectin-1 receptors in different cell types. J Biomed Sci, v. 12(1), p. 13-29, 2005.
13. EUSEBI, V. et al. Transcontinental consults in surgical pathology via the internet. Hum Pathol, v. 28, p. 13-6, 1997.
14. FAGGIANO, A. et al. Differential expression of galectin 3 in solid cell nests and C cells of human thyroid. J Clin Pathol, v. 56, p. 142-3, 2003.
15. FELLEPA, E. J. et al. Three-dimensional ultrasound analysis of the prostate. Molecular Urology, v. 4(3), p. 133-9, 2000.
16. FIGUERÊDO-SILVA, J. et al. Esquistossomose mansônica experimental: estudo morfométrico e experimental das células caliciformes intestinais. An Fac Med Univ Fed Pernamb, v. 44, p. 21-5, 1999.
17. FODDY, L.; STAMATOGLOU, S. C.; HUGHES, R. C. An endogenous carbohydrate-binding protein of baby hamster kidney (BHK21 C13) cells. Temporal changes in cellular expression in the developing kidney. J Cell Sci, v. 97, p. 139-48, 1990.
18. FRANCOIS, C. et al. Galectin-1 and galectin-3 binding pattern expression in renal cell carcinomas. Am J Clin Pathol, v. 112, p. 194-203, 1999.
19. HELIN, H. O. et al. Virtual microscopy in prostate histopathology: simultaneous viewing of biopsies stained sequentially with hematoxylin and eosin, and methylacyl-coenzyme a racemase/p63 immunohistochemistry. J Urol, v. 175, p. 495-9, 2006.
20. HERLING, M. et al. Glycohistochemical monitoring of chemically induced sarcomas at different stages of tumorigenesis. In Vivo, v. 14(4), p. 499-506, 2000.
21. HERMAN, C. J. Image cytometry in pathology. Hum Pathol, v. 27, p. 435-6, 1996.
22. HONJO, Y. et al. Expression of cytoplasmic galectin-3 as a prognostic marker in tongue carcinoma. Clin Cancer Res, v. 6, p. 4635-40, 2000.
23. INUFUSA, H. et al. Role of galectin-3 in adenocarcinoma liver metastasis. Int J Oncology, v. 19, p. 913-9, 2001.
24. IRIMURA, T. et al. Increased content of an endogenous lactose-binding lectin in human colorectal carcinoma progressed to metastatic stages. Cancer Res, v. 51, p. 387-93, 1991.
25. LE MARER, N.; HUGHES, R. C. Effects of the carbohydrate-binding protein galectin-3 on the invasiveness of human breast carcinoma cells. J Cell Physiol, v. 168, p. 51-8, 1996.
26. LOTAN, R. et al. Lactose-binding lectin expression in human colorectal carcinomas. Relation to tumor progression. Carbohydr Res, v. 213, p. 47-57, 1991.
27. MONTIRONI, R. et al. Nuclear changes in the normal-looking columnar epithelium adjacent to and distant from prostatic intraepithelial neoplasia and prostate cancer. Morphometric analysis in whole-mount sections. Virchows Archives, v. 437(6), p. 625-34, 2000.
28. MULLER, W. E. Origin of metazoan adhesion molecules and adhesion receptors as deduced from cDNA analyses in the marine sponge Geodia cydonium: a review. Cell Tissue Res, v. 289, p. 383-95, 1997.
29. NANGIA-MAKKER, P. et al. Regulation of the expression of galactoside-binding lectin during human monocytic differentiation. Cancer Res, v. 53, p. 5033-7, 1993.
30. NOVIK, V. I. The use of computer technology in the cytologic diagnosis of neoplasms. Vopr Onkol, v. 46(2), p. 239-42, 2000.
31. OBERHOLZER, M. et al. Methods in quantitative image analysis. Histochem Cell Biol, v. 105, p. 333-55, 1996.
32. OKUYAMA T. et al. Interrelation between tumor-associated cell surface glycoprotein and host immune response in gastric carcinoma patients. Cancer, v. 82(8), p. 1468-75, 1998.
33. PACIS, R. A. et al. Decreased galectin-3 expression in prostate cancer. Prostate, v. 44(2), p. 118-23, 2000.
34. PARON, I. et al. Nuclear localization of galectin-3 in transformed thyroid cells: a role in transcriptional regulation. Biochem Biophys Res Commun, v. 302, p. 545-53, 2003.
35. PIANTELLI, M. et al. Lack of expression of galectin-3 is associated with a poor outcome in node-negative patients with laryngeal squamous-cell carcinoma. J Clin Oncol, v. 20, p. 3850-6, 2002.
36. PUGLISI, F. et al. Galectin-3 expression in non-small cell lung carcinoma. Cancer Lett, v. 212, p. 233-9, 2004.
37. RASHBASS, J. The impact of information technology on histopathology. Histopathology, v. 36(1), p. 1-7, 2000.
38. RAZ, A.; LOTAN, R. Endogenous galactoside-binding lectins: a new class of functional tumor cell surface molecules related to metastasis. Cancer Metastasis Rev, v. 6, p. 433-52, 1987.
39. RAZ, A.; CARMI, P.; PAZERINI, G. Expression of two different endogenous galactoside-binding lectins sharing sequence homology. Cancer Res, v. 48, p. 645-9, 1988.
40. RAZ, A. et al. Molecular cloning and chromosomal mapping of a human galactoside-binding protein. Cancer Res, v. 51, p. 2173-8, 1991.
41. SCHAFFERT, C.; POUR, P. M.; CHANEY, W. G. Localization of galectin-3 in normal and diseased pancreatic tissue. Int J Pancreatol, v. 23, p. 1-9, 1998.
42. SHEKHAR, M. P. et al. Alterations in galectin-3 expression and distribution correlate with breast cancer progression: functional analysis of galectin-3 in breast epithelial/endothelial interactions. Am J Pathol, v. 165, p. 1931-41, 2004.
43. SHIMAMURA, T. et al. Clinicopathological significance of galectin-3 expression in ductal adenocarcinoma of the pancreas. Clin Cancer Res, v. 8, p. 2570-5, 2002.
44. TAKAHASHI, T. et al. Alpha 1,6 fucosyltransferase is highly and specifically expressed in human ovarian serous adenocarcinomas. Int J Cancer, v. 88(6), p. 914-9, 2000.
45. VAN BEMMEL, J. H.; MUSEN, M. A. Biostatistical methods. In: VAN BEMMEL, J. H.; MUSEN, M. A. (eds.). Handbook of Medical Informatics. Germany: Springer-Velag, 1997. Cap. 24, p. 387-96.
46. VAN DEN BRULE, F.; CALIFICE, S.; CASTRONOVO, V. Expression of galectins in cancer: a critical review. Glycoconj J, v. 19, p. 537-42, 2004.
47. VAN DEN BRULE, F. A. et al. Galectin-3, a laminin binding protein, fails to modulate adhesion of human melanoma cells to laminin. Neoplasma, v. 42, p. 215-9, 1995.
48. VAN DEN BRULE, F. A. et al. Alteration of the cytoplasmic/nuclear expression pattern of galectin-3 correlates with prostate carcinoma progression. Int J Cancer, v. 89, p. 361-7, 2000.
49. WAWROSCHEK, F. et al. The influence of serial sections, immunohistochemistry, and extension of pelvic lymph node dissection on the lymph node status in clinically localized prostate cancer. Eur Urol, v. 43, p. 132-7, 2003.
50. YU, L.G. et al. Opposite effects on human colon cancer cell proliferation of two dietary Thomsen-Friedereich antigen-binding lectins. J Cell Physiol, v. 186(2), p. 282-7, 2001.